1. Home
  2. REVB vs BAOS Comparison

REVB vs BAOS Comparison

Compare REVB & BAOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • REVB
  • BAOS
  • Stock Information
  • Founded
  • REVB 2020
  • BAOS 2018
  • Country
  • REVB United States
  • BAOS China
  • Employees
  • REVB N/A
  • BAOS N/A
  • Industry
  • REVB Biotechnology: Pharmaceutical Preparations
  • BAOS Business Services
  • Sector
  • REVB Health Care
  • BAOS Consumer Discretionary
  • Exchange
  • REVB Nasdaq
  • BAOS Nasdaq
  • Market Cap
  • REVB 3.7M
  • BAOS 3.4M
  • IPO Year
  • REVB N/A
  • BAOS 2021
  • Fundamental
  • Price
  • REVB $0.75
  • BAOS $2.75
  • Analyst Decision
  • REVB
  • BAOS
  • Analyst Count
  • REVB 0
  • BAOS 0
  • Target Price
  • REVB N/A
  • BAOS N/A
  • AVG Volume (30 Days)
  • REVB 2.9M
  • BAOS 2.0M
  • Earning Date
  • REVB 08-08-2025
  • BAOS 07-07-2025
  • Dividend Yield
  • REVB N/A
  • BAOS N/A
  • EPS Growth
  • REVB N/A
  • BAOS N/A
  • EPS
  • REVB N/A
  • BAOS N/A
  • Revenue
  • REVB N/A
  • BAOS $624,087.00
  • Revenue This Year
  • REVB N/A
  • BAOS N/A
  • Revenue Next Year
  • REVB N/A
  • BAOS N/A
  • P/E Ratio
  • REVB N/A
  • BAOS N/A
  • Revenue Growth
  • REVB N/A
  • BAOS N/A
  • 52 Week Low
  • REVB $0.71
  • BAOS $1.44
  • 52 Week High
  • REVB $56.00
  • BAOS $13.66
  • Technical
  • Relative Strength Index (RSI)
  • REVB 24.83
  • BAOS 55.12
  • Support Level
  • REVB $0.74
  • BAOS $2.47
  • Resistance Level
  • REVB $0.98
  • BAOS $3.02
  • Average True Range (ATR)
  • REVB 0.06
  • BAOS 0.33
  • MACD
  • REVB 0.07
  • BAOS -0.05
  • Stochastic Oscillator
  • REVB 14.81
  • BAOS 29.51

About REVB Revelation Biosciences Inc.

Revelation Biosciences Inc is a clinical-stage life science company that is focused on rebalancing inflammation to optimize health using its proprietary formulation Gemini. It is developing a pipeline of potential high-value products based on Gemini. Gemini is Revelation's proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD) an established TLR4 agonist that can stimulate the human body's innate immune response to prevent and treat disease. The product candidates are developed are based on Gemini formulation of PHAD. Gemini-based programs consist of: Gemini-SSI developed for the prevention of surgical site infection (SSI); Gemini-AKI developed for the prevention of acute kidney injury (AKI); and Gemini-CKD for the treatment of chronic kidney disease (CKD).

About BAOS Baosheng Media Group Holdings

Baosheng Media Group Holdings Ltd operates as a V-log streaming marketing service provider. The firm offers comprehensive marketing solutions. Its services are Internet effect marketing, V-log or short video streaming marketing including content production and operation, e-commerce marketing, original big data platform system service, and AI technology. It provides one-stop and full-link deep customized marketing solutions for partners. Baosheng Group is also a core agency of domestic Internet companies such as Tencent, Alibaba, Bytedance, and Kuaishou, with performing channel marketing services, technologies, and applications.

Share on Social Networks: